The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry: Q3D Elemental Impurities



Developing a strategy to limit elemental impurities in the drug product is consistent with risk management processes identified in ICH Q9.

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information